Unit 5 Discussion: Abuse/Trauma in relation to LGBTQ

Unit 5 Discussion: Abuse/Trauma in relation to LGBTQ

Unit 5 Discussion: Abuse/Trauma in relation to LGBTQ

Trauma/Abuse in relation to LGBTQI behavioral/mental health.
write a synthesis paper that addresses the following sections:
• Introduction to topic
• Epidemiology and economic costs
• Overview of the assessment/tools to assess/DSM-5
• Pharmacological interventions with specifics to dynamics, kinetics, contraindications, side effects, and so on
• Plan of care to include collaborative interventions and psychotherapeutic options

ORDER A PLAGIARISM-FREE Unit 5 Discussion: Abuse/Trauma in relation to LGBTQ HERE

Good News For Our New customers . We can help you in Completing this assignment and pay after Delivery. Our Top -rated medical writers will comprehensively review instructions , synthesis external evidence sources(Scholarly) and customize a quality assignment for you. We will also attach a copy of plagiarism report alongside, AI report alongside the assignment. Feel free to chat Us

Trauma/Abuse Concerning LGBTQI

Considering that LGBTQI represents a minority group in society, its members face various social stigmas and discrimination. Also, mental health centers and healthcare providers often find it hard to address mental illnesses that face LGBTQI members, such as developing programs that foster recognition of LGBTQI clients’ needs.  As a result, most LGBTQI members who result from experiencing these negative treatments may end up being traumatized or committing suicide, thus deteriorating their mental health. Therefore, the paper aims to evaluate LGBTQI’s epidemiology and economic cost, DSM-5 tools assessment overview, pharmacological interventions, plan of care.

LGBTQI’s Epidemiology and Economic Cost

The LGBTQI individuals encompass all social classes, religions, ethnicities, and races. According to Harvey (2021), the LGBTQI number cannot be easily estimated, including their health needs, since most state and national surveys do not ask gender identity and sexual orientation questions. However, most researches indicate that LGBTQI member faces different health disparities that are linked to denial of human and civil rights, discrimination, and societal stigma. For example, Coulter et al. (2020) postulate that when LGBTQI individuals face discrimination, there are high chances that these people will develop high rates of substance abuse, suicide, and psychiatric disorders. Also, when these individuals face victimization and violence either by their communities or families, such actions leave long-lasting mental effects on them. For instance, Coulter et al. (2020) assert that in 2010, the Healthy People document suggested a need to research more on LGBTQI to foster understanding and address the most adverse environmental issues that lead to their health disparities. That is because when health disparities that face them become eliminated, the individuals will lead to healthy and long lives, reduce health care costs reductions and increase physical and mental well-being.

Concerning economic cost, the LGBTQI experiences affect these individuals and their families only since the countries also experience economic heat associated with homophobia. Harvey (2021) asserts that from a report by the world bank in 2015, India lost $32 billion in its economic output due to LGBT individuals’ discrimination. As a result, the government has a role to play by passing new policies and laws to protect the LGBTQI group’s unfair treatment.

DSM-5 Tools Assessment Overview

Understanding LGBTQI community history in the psychiatry profession is essential since civil rights activists have shaped the current DSM-5 treatment. As a result, Coulter et al. (2020) ascertain that despite fears of discrimination as the LGBTQI group seeks psychiatry help, gender and sexuality assessment tools are developed that involve masculine and feminine assessments. Out of these tools, the main assessment realms revolve around sexuality behavior, gender identification, sexual attraction, and gender role and expression.

Pharmacological Intervention

The main pharmacological intervention to treat trauma experienced by the LGBTQI group includes paroxetine, whose brand name is Seroxat, an antidepressant. Generally, paroxetine can be prescribed as a liquid or tablets for adults 18 years and above. As Feduccia et al. (2019) indicate, paroxetine takes between 4 to 6 weeks to work. This drug is associated with multiple side effects, including headache, weakness, dizziness, difficulty concentrating, forgetfulness, nervousness, sleepiness, and confusion. In case of any complication, the doctor helps the patient to withdraw from the drug gradually to prevent further side effects. This drug should not be taken by individuals with manic behavior, suicidal thoughts, or manic-depression.

Care Plan

During trauma treatment plans, the psychiatrist and other healthcare providers like pharmacists should collaborate to ensure that the patient receives quality care. For instance, the psychiatrist should keenly diagnose the best medication the pharmacist will provide to the patient with accurate information on how to use it. Consequently, with the help of their families, the patient will need to follow the psychiatrist and pharmacist’s instructions to improve the overall quality of care. Additionally, primary care providers should be involved to diagnose and treat other primary conditions, thus providing the client with holistic care.

Conclusion

The paper discusses the LGBTQI’s epidemiology and economic cost, DSM-5 tools assessment overview, pharmacological interventions, and care plan. These factors prove the need to train healthcare providers on better ways to handle LGBTQI patients to prevent more mental adverse effects.

ORDER A PLAGIARISM-FREE Unit 5 Discussion: Abuse/Trauma in relation to LGBTQ HERE

References

Coulter, R. W., Siconolfi, D. E., Egan, J. E., & Chugani, C. D. (2020). Advancing LGBTQ health equity via human-centered design. Psychiatric Services, 71(2), 109-109.

Feduccia, A. A., Jerome, L., Klosinski, B., Emerson, A., Mithoefer, M. C., & Doblin, R. (2019). Breakthrough for trauma treatment: safety and efficacy of MDMA-assisted psychotherapy compared to paroxetine and sertraline. Frontiers in psychiatry, 10, 650.

Harvey, M. (2021). The Political Economy of Health: Revisiting Its Marxian Origins to Address 21st-Century Health Inequalities. American Journal of Public Health, 111(2), 293-300.